Similar articles

• Inhibition of RANKL improves the skeletal phenotype of adenine-induced chronic kidney disease in mice.

  Metzger CE, Kittaka M, LaPlant AN, Ueki Y, Allen MR. Metzger CE, et al. JBMR Plus. 2024 Jan 14;8(2):ziae004. doi: 10.1093/jbmrpl/ziae004. eCollection 2024 Feb. JBMR Plus. 2024. PMID: 38505524 Free PMC article.
• Strain-specific alterations in the skeletal response to adenine-induced chronic kidney disease are associated with differences in parathyroid hormone levels.

  Metzger CE, Swallow EA, Stacy AJ, Allen MR. Metzger CE, et al. Bone. 2021 Jul;148:115963. doi: 10.1016/j.bone.2021.115963. Epub 2021 Apr 17. Bone. 2021. PMID: 33878503 Free PMC article.
• Correction to: Osteoclast-specific Plastin 3 knockout in mice fail to develop osteoporosis despite dramatic increased osteoclast resorption activity.

  [No authors listed] [No authors listed] JBMR Plus. 2024 Mar 27;8(4):ziae042. doi: 10.1093/jbmrpl/ziae042. eCollection 2024 Apr. JBMR Plus. 2024. PMID: 38544921 Free PMC article.
• Correction to: Fructooligosaccharides act on the gut-bone axis to improve bone independent of Tregs and alter osteocytes in young adult C57BL/6 female mice.

  [No authors listed] [No authors listed] JBMR Plus. 2024 May 3;8(6):ziae055. doi: 10.1093/jbmrpl/ziae055. eCollection 2024 Jun. JBMR Plus. 2024. PMID: 38706879 Free PMC article.
• Correction to: Open-label extension of a randomized trial investigating safety and efficacy of rhPTH(1-84) in hypoparathyroidism.

  [No authors listed] [No authors listed] JBMR Plus. 2024 May 17;8(6):ziae068. doi: 10.1093/jbmrpl/ziae068. eCollection 2024 Jun. JBMR Plus. 2024. PMID: 38764791 Free PMC article.